Firdapse Developer Catalyst Will Hold Rare Disease Day Event on Feb. 26

Firdapse Developer Catalyst Will Hold Rare Disease Day Event on Feb. 26

287940

Firdapse Developer Catalyst Will Hold Rare Disease Day Event on Feb. 26

Firdapse (amifampridine) developer Catalyst Pharmaceuticals is supporting Rare Disease Day 2021 by sponsoring and participating in a virtual Facebook Live event on Friday, Feb. 26, at 4 p.m. ET. The live event, streaming on Facebook, will feature a discussion panel that includes a patient advocate with Lambert-Eaton myasthenic syndrome (LEMS), the company announced in a press release. “We are proud to support the effort to build unity within the rare and ultra-rare disease community,” said Patrick…

You must be logged in to read/download the full post.